Glaukos to Release Third Quarter 2026 Financial Results after Market Close on October 28
Business Wire•07/10/2026•07:00 ET
0
Key Highlights
- ➤Glaukos (GKOS) will release third-quarter 2026 results after market close October 28
- ➤Management conference call and webcast scheduled for 1:30 p.m. PT October 28
- ➤Glaukos commenced commercial launch activities for iDose TR in 2024
Glaukos to Release Third Quarter 2026 Financial Results after Market Close on October 28
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, plans to release third quarter 2026 financial results after the market close on Wednesday, October 28, 2026. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on October 28, 2026.
Get started
Create a free account to read the full story.